Healthcare systems, the State, and innovation in the pharmaceutical industry
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Artigo |
Idioma: | eng por |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224 |
Resumo: | This article discusses the relations between healthcare systems and the pharmaceutical industry, focusing on state support for pharmaceutical innovation. The study highlights the experiences of the United States, United Kingdom, and Germany, developed countries and paradigms of modern health systems (liberal, universal, and corporatist), in addition to Japan, a case of successful catching up. The study also emphasizes the experiences of China, India, and Brazil, large developing countries that have tried different catching up strategies, with diverse histories and profiles in their healthcare systems and pharmaceutical industries. Finally, with a focus on state forms of support for health research, the article addresses the mechanisms for linkage between health systems and the pharmaceutical industry, evaluating the possibilities of Brazil strengthening a virtuous interaction, favoring the expansion and consolidation of the Brazilian health system - universal but segmented ‒ and the affirmation of the innovative national pharmaceutical industry. |
id |
FIOCRUZ-5_7a1317499f46d5d28a44cccc7fc6676a |
---|---|
oai_identifier_str |
oai:ojs.teste-cadernos.ensp.fiocruz.br:article/6224 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Healthcare systems, the State, and innovation in the pharmaceutical industrySistemas de atenção à saúde, Estado e inovação na indústria farmacêuticaDrug IndustryHealth SystemsPublic PoliciesSustainable DevelopmentInnovationIndústria FarmacêuticaSistemas de SaúdePolíticas PúblicasDesenvolvimento SustentávelInovaçãoThis article discusses the relations between healthcare systems and the pharmaceutical industry, focusing on state support for pharmaceutical innovation. The study highlights the experiences of the United States, United Kingdom, and Germany, developed countries and paradigms of modern health systems (liberal, universal, and corporatist), in addition to Japan, a case of successful catching up. The study also emphasizes the experiences of China, India, and Brazil, large developing countries that have tried different catching up strategies, with diverse histories and profiles in their healthcare systems and pharmaceutical industries. Finally, with a focus on state forms of support for health research, the article addresses the mechanisms for linkage between health systems and the pharmaceutical industry, evaluating the possibilities of Brazil strengthening a virtuous interaction, favoring the expansion and consolidation of the Brazilian health system - universal but segmented ‒ and the affirmation of the innovative national pharmaceutical industry.El artículo discute las relaciones entre los sistemas de salud y la industria farmacéutica, concentrándose en el apoyo del Estado a la innovación farmacéutica. Resalta las trayectorias de los Estados Unidos, Reino Unido y Alemania, países desarrollados, paradigmáticos de los modernos sistemas de salud (liberales, universales y corporativos), además de Japón, un caso de emparejamiento exitoso. También enfatiza las trayectorias de China, India y Brasil, países en desarrollo, extensos, que experimentaron diferentes estrategias de emparejamiento en este ámbito, disponiendo de sistemas de salud e industrias farmacéuticas con trayectorias y perfiles diversos. Finalmente, centrándose en las formas estatales de apoyo a la investigación en salud, se consideran los mecanismos de conexión entre los sistemas de salud y la industria farmacéutica, evaluando las posibilidades, en Brasil, de fortalecer una interacción virtuosa que favorezca la expansión y consolidación del sistema de salud brasileño -universal, pese a estar segmentado-, y la consolidación de la industria farmacéutica nacional innovadora.O artigo discute as relações entre os sistemas de saúde e a indústria farmacêutica, concentrando-se no apoio do Estado à inovação farmacêutica. Salienta as trajetórias dos Estados Unidos, Reino Unido e Alemanha, países desenvolvidos, paradigmáticos dos modernos sistemas de saúde (liberais, universais e corporativos), além do Japão, um caso de emparelhamento bem-sucedido. Também enfatiza as trajetórias de China, Índia e Brasil, países em desenvolvimento, extensos, que experimentaram diferentes estratégias de emparelhamento, dispondo de sistemas de saúde e indústrias farmacêuticas com trajetórias e perfis diversos. Finalmente, com foco nas formas estatais de apoio à pesquisa em saúde, considera os mecanismos de conexão entre os sistemas de saúde e a indústria farmacêutica, avaliando as possibilidades, no Brasil, de fortalecer uma interação virtuosa que favoreça a expansão e consolidação do sistema de saúde brasileiro - universal, conquanto segmentado ‒ e a afirmação da indústria farmacêutica nacional inovadora.Reports in Public HealthCadernos de Saúde Pública2016-11-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmltext/htmlapplication/pdfapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224Reports in Public Health; Vol. 32 No. 14 (2016): Supplement 2Cadernos de Saúde Pública; v. 32 n. 14 (2016): Suplemento 21678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZengporhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13202https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13203https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13204https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13205Ignacio José Godinho Delgadoinfo:eu-repo/semantics/openAccess2024-03-06T15:29:12Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/6224Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:07:06.809410Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true |
dc.title.none.fl_str_mv |
Healthcare systems, the State, and innovation in the pharmaceutical industry Sistemas de atenção à saúde, Estado e inovação na indústria farmacêutica |
title |
Healthcare systems, the State, and innovation in the pharmaceutical industry |
spellingShingle |
Healthcare systems, the State, and innovation in the pharmaceutical industry Ignacio José Godinho Delgado Drug Industry Health Systems Public Policies Sustainable Development Innovation Indústria Farmacêutica Sistemas de Saúde Políticas Públicas Desenvolvimento Sustentável Inovação |
title_short |
Healthcare systems, the State, and innovation in the pharmaceutical industry |
title_full |
Healthcare systems, the State, and innovation in the pharmaceutical industry |
title_fullStr |
Healthcare systems, the State, and innovation in the pharmaceutical industry |
title_full_unstemmed |
Healthcare systems, the State, and innovation in the pharmaceutical industry |
title_sort |
Healthcare systems, the State, and innovation in the pharmaceutical industry |
author |
Ignacio José Godinho Delgado |
author_facet |
Ignacio José Godinho Delgado |
author_role |
author |
dc.contributor.author.fl_str_mv |
Ignacio José Godinho Delgado |
dc.subject.por.fl_str_mv |
Drug Industry Health Systems Public Policies Sustainable Development Innovation Indústria Farmacêutica Sistemas de Saúde Políticas Públicas Desenvolvimento Sustentável Inovação |
topic |
Drug Industry Health Systems Public Policies Sustainable Development Innovation Indústria Farmacêutica Sistemas de Saúde Políticas Públicas Desenvolvimento Sustentável Inovação |
description |
This article discusses the relations between healthcare systems and the pharmaceutical industry, focusing on state support for pharmaceutical innovation. The study highlights the experiences of the United States, United Kingdom, and Germany, developed countries and paradigms of modern health systems (liberal, universal, and corporatist), in addition to Japan, a case of successful catching up. The study also emphasizes the experiences of China, India, and Brazil, large developing countries that have tried different catching up strategies, with diverse histories and profiles in their healthcare systems and pharmaceutical industries. Finally, with a focus on state forms of support for health research, the article addresses the mechanisms for linkage between health systems and the pharmaceutical industry, evaluating the possibilities of Brazil strengthening a virtuous interaction, favoring the expansion and consolidation of the Brazilian health system - universal but segmented ‒ and the affirmation of the innovative national pharmaceutical industry. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-11-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224 |
url |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13202 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13203 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13204 https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/6224/13205 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html text/html application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
publisher.none.fl_str_mv |
Reports in Public Health Cadernos de Saúde Pública |
dc.source.none.fl_str_mv |
Reports in Public Health; Vol. 32 No. 14 (2016): Supplement 2 Cadernos de Saúde Pública; v. 32 n. 14 (2016): Suplemento 2 1678-4464 0102-311X reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1798943382495559680 |